Earum Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 114.1 million compared to INR 388.51 million a year ago. Revenue was INR 136.93 million compared to INR 418.38 million a year ago. Net income was INR 19.87 million compared to net loss of INR 16.27 million a year ago. Basic earnings per share from continuing operations was INR 0.312 compared to basic loss per share from continuing operations of INR 0.264 a year ago. Diluted earnings per share from continuing operations was INR 0.312 compared to diluted loss per share from continuing operations of INR 0.264 a year ago.